GET THE APP

Leading Journals In Stem Cell Transplantation | Open Access Journals
Journal of Blood & Lymph

Journal of Blood & Lymph

ISSN: 2165-7831

Open Access

Leading Journals In Stem Cell Transplantation

Hematopoietic stem cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood or umbilical cord blood. It can be autologous (the patient's own stem cells are used), allogeneic (stem cells come from a donor) or syngeneic (from an identical twin). It is most often performed for patients with certain cancers of the blood or bone marrow, such as multiple myeloma or leukemia. In these cases, the recipient's immune system is usually destroyed by radiotherapy or chemotherapy before transplantation. Infection and graft versus host disease are major complications of allogenic GCSH. Hematopoietic stem cell transplantation remains a dangerous procedure with many possible complications; it is reserved for patients with fatal diseases. As survival after the procedure increased, its use has spread beyond cancer to autoimmune diseases and hereditary skeletal dysplasia; including infantile malignant osteopetrosis and mucopolysaccharidosis. Many recipients of GCSH are patients with multiple myeloma or leukemia who would not benefit from or are already resistant to long-term treatment with chemotherapy

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Google Scholar citation report
Citations: 443

Journal of Blood & Lymph received 443 citations as per Google Scholar report

Journal of Blood & Lymph peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward